NewsRoom Articles - Page 42 of 48

WednesdayAug 03, 2022 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Poised to Become World’s Go-to Lidar Supplier for Auto Industry; Partnership with Fabrinet Marks New Milestone in Pursuit of Leadership

Cepton has selected Fabrinet, a leading-edge provider of precision optical, electro-mechanical and electronic manufacturing services, to produce its flagship automotive-grade Vista(R)-X90 lidarPartnership with Fabrinet, known for its advanced manufacturing capabilities and deep precision-manufacturing expertise, allows Cepton to advance on its path toward making lidar an essential part of consumer vehiclesThis collaboration marks a strategic milestone as it allows Cepton to accelerate production and drive the company's growth at scale "At Cepton, our goal is to be the world's go-to supplier of automotive lidar solutions, and working with an OEM-trusted and validated manufacturing partner is a crucial part of that effort,"…

TuesdayAug 02, 2022 11:15 am

Aditxt Inc. (NASDAQ: ADTX) Seeks to Address Variability of Immune Responses

Biotech innovation company, Aditxt, Inc (“Aditxt” or the “Company”) is developing and commercializing technologies focused on monitoring and reprogramming the immune system Their ground-breaking ADi(TM) immune reprogramming platform will be initially directed towards the treatment of psoriasis, type 1 diabetes and skin allograftingThe Company has also recently begun to commercialize their AditxtScore(TM) proprietary immune mapping technology, which is designed to provide individuals with personalized reports on their immune systemThe AditxtScore(TM) system is initially focused on providing customers with reports looking into their vulnerability and immune response to SARS-CoV-2 and its known variants Every 9 minutes, a person is placed on an…

TuesdayAug 02, 2022 10:00 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Surfs the Rising Wave of Metaverse Gaming

The popularity of online gaming is set to be further boosted through the advent of ‘Metaverse’ gamingMetaverse gaming allows for users to enhance their virtual gaming experience, interacting socially with their peers to mimic a realistic, casino experience in the comfort of their homesThe development is also of great appeal to gaming providers, given the higher levels of transparency, security, and privacy involved relative to traditional casinosThe growth in online gaming has spurred the creation of thousands of online gaming providers, with the vast majority opting to procure their operational systems from third-party ‘SaaS’ providersThe trend has benefitted GMGI, with…

TuesdayAug 02, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expanding Scope of Potentially Pivotal Study as Part of Clinical Program to Develop GBM Treatment

CNS Pharmaceuticals is undertaking a Berubicin clinical development program targeting glioblastoma multiforme (“GBM”), the most common and devastating primary malignant brain tumorGBM has an incidence rate of 3.21 per 100,000 in the U.S. and up to 5 per 100,000 globally, with studies noting that the latter figure is risingCNS recently received approval for a protocol amendment as part of its potentially pivotal study evaluating the efficacy and safety of Berubicin for the treatment of GBMThe amendment expands eligibility for its potentially pivotal study to patients who have received additional treatments as part of the first-line therapyCNS is looking to expand…

MondayAug 01, 2022 9:45 am

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) ‘Meets Definition of Domestic Clean-Energy Infrastructure,’ Op-Ed Concludes

Denver Post op-ed piece reports no evidence that tailings cells are leaking or contaminating groundwaterU.S. goal to cut emissions in half calls for greater support, investment in domestic manufacturing of clean-energy technologiesCommunicating correct facts can help others recognize that White Mesa Mill is not a threatening or dangerous neighbor After concerns surfaced about the impact a Utah uranium mill might have on the surrounding water sources, an op-ed piece in the Denver Post reported that there is “no evidence that implies the tailings cells are leaking or contaminating groundwater” (https://ibn.fm/4ZfQT). That assessment aligns with what Energy Fuels (NYSE American: UUUU)…

FridayJul 29, 2022 10:30 am

iGaming Legalized in Ontario, Golden Matrix Group Inc. (NASDAQ: GMGI) Positioned to Benefit from Relaxed Legislation

Canadian province of Ontario recently legalized iGaming, other provinces expected to followiGaming industry expected to reach 153.6 billion by 2030 at CAGR of 11.7% from 2022 to 2030GMGI offers highly modular, turnkey, and white label gaming solutions for growing B2B customer baseRecently released financial results reveal 15 consecutive profitable quarters, 221% Q2-2022 growth The province of Ontario in Canada has recently joined South Africa, Japan, and many European Union countries in legalizing iGaming (https://ibn.fm/65kyx). Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, is positioned to benefit from relaxed legislation that is…

WednesdayJul 27, 2022 10:30 am

Cepton, Inc. (NASDAQ: CPTN) Set to Capitalize on Lidar Sector’s Exponential Growth Trends

Originally designed to map out the meteorology of early weather, lidar sensor technology has powered/enabled a wide range of innovative applications The rapid development and adoption of lidar technology is expected to drive the sector to grow to a value of EUR 50 billion per annumCepton, Inc. has been a key beneficiary of sectoral growth, having earlier been awarded the largest ADAS lidar contract by an automotive OEM in historyThe company has also pioneered the usage of lidar technology in alternative applications worldwide, recently collaborating with Fibre Based Integrations to revamp Cape Town’s traffic infrastructure using their proprietary technology In the…

TuesdayJul 26, 2022 1:00 pm

Golden Matrix Group Inc. (NASDAQ: GMGI) Reports Fastest 1QFY2022 Revenue Growth within the Online Gaming Sector

Golden Matrix Group recorded revenue growth of +355% YoY in 1QFY22, the highest growth rate within the online gaming sector Golden Matrix attributed part of the increase to strong revenue contributions from UK-based RKingsCompetitions Ltd, which it purchased an 80% stake in as of November 2021RKings has emerged as one of the UK’s largest online competition companies, reporting revenues of over $32 million last yearThe acquisition of RKings bodes favourably for GMGI’s bid to further expand their B2C segment whilst geographically diversifying their revenue stream away from their traditional Asia-Pacific based B2B clientele The online gaming market is on a roll.…

MondayJul 25, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent

Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patentsRecently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a new patent to be granted in JapanThe patent is the fourth to be granted in Japan and the first patent issued from Lexaria’s seventh patent familyLexaria also submitted a briefing book to the FDA to facilitate its upcoming pre-Investigational New Drug (“IND”) meeting with the agency “We are extremely pleased to have received our first patent protecting our proprietary technology… I…

MondayJul 25, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Completes Acquisition of Largest-Ever DMT Study

Data from newly acquired study could accelerate clinical development of CYBN’s CYB004 by nine monthsThe pivotal study was designed with four primary objectivesCybin’s proprietary substance has potential to effectively treat anxiety disorders, including GAD and SAD Cybin (NEO: CYBN) (NYSE American: CYBN) has completed the acquisition of the largest dimethyltryptamine (“DMT”) study to date, a Phase 1 N,N-DMT study that provides key data relating to the company’s proprietary CYB004 substance (https://ibn.fm/2Ab0T). Information from the study is expected to help the company accelerate by up to nine months its clinical development pathway of CYB004. “With the closing of this transaction we are…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000